- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0004299

About Yeluri Formulations Private Limited
Data last updated:
Yeluri Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1997PTC026188. Its GSTIN is 36AAACY1267G1ZC (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3.15 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Yeluri Hari Prasad (Managing Director) and Eluri Nageswara Rao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3rd Floor A.V.M. Towers Beside Siva Parvathi Theatre Opp: Kphb Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.05 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹65.56 Lakh (net margin 0.7%) and EBITDA of ₹4.27 Cr (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.
The company has about 69 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Yeluri. As per MCA filings, the company has open charges of ₹57.33 Cr and satisfied charges of ₹40.78 Cr on record. Court records list 17 cases involving the company, including 5 filed by the company and 12 filed against it; 4 cases are pending. The company has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.05 Cr; the latest was in August 2022. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Veer Chemie and Aromatics Pvt Ltd with revenue of ₹97.47 Cr.
Yeluri Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0004299). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website yeluri.net.
Company details
CIN history
Yeluri Formulations has one previous CIN (Corporate Identification Number): U24230AP1997PTC026188. The current CIN is U24230TG1997PTC026188, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1997PTC026188 | Current |
| U24230AP1997PTC026188 | Previous |
Recognitions & Rankings of Yeluri Formulations
Contact details
Yeluri Formulations Private Limited's registered office is in Hyderabad, Telangana. Its website is yeluri.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor A.V.M. Towers Beside Siva Parvathi Theatre Opp: Kphb Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Yeluri Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Yeluri Formulations operates one associated brand: Yeluri. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures traditional pharmaceutical formulations for the healthcare industry. | yeluri.net |
Business activity
The main business activity of Yeluri Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Yeluri Formulations Private Limited, buy the company report.
Financials of Yeluri Formulations Private Limited
FY 2024 filings availableYeluri Formulations Private Limited reported revenue of ₹96.05 Cr (down 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yeluri Formulations Private Limited, buy the company report.
Board of directors of Yeluri Formulations Private Limited
Yeluri Formulations has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manogna Yeluri | Additional Director | 28 Jun 2021 | 5 Years 4 Months | Current |
| Eluri Nageswara Rao | Director | 01 Apr 2009 | 17 Years 7 Months | Current |
| Eluri Sridevi | Director | 01 Apr 2009 | 17 Years 7 Months | Current |
| Yeluri Hari Prasad | Managing Director | 01 Apr 2009 | 17 Years 7 Months | Current |
Peer comparison
Yeluri Formulations Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Veer Chemie and Aromatics Pvt Ltd | ₹97.47 Cr (FY 2024) | 11.0% | Telangana, India | |||
| Pharma Chem Industries (Gujarat) Private Limited | ₹97.24 Cr (FY 2025) | 20.0% | Vapi, Gujarat, India | |||
| V S International Private Limited | ₹96.26 Cr (FY 2024) | 65.0% | Mumbai, Maharashtra, India | |||
| XL Laboratories Private Limited | ₹96.06 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Yeluri Formulations Private Limitedthis company | ₹96.05 Cr (FY 2025) | ₹65.56 Lakh | 0.7% | -23.0% | 69 | Hyderabad, Telangana, India |
| MCW Healthcare Private Limited | ₹95.35 Cr (FY 2024) | 16.0% | Madhya Pradesh, India | |||
| Surmount Laboratories Limited | ₹95.33 Cr (FY 2024) | -6.0% | Mumbai, Maharashtra, India | |||
| Ang Lifesciences India Limited | ₹94.87 Cr (FY 2025) | -35.0% | Amritsar, Punjab, India | |||
| Bio-Med Private Limited | ₹94.67 Cr (FY 2025) | 19.0% | Uttar Pradesh, India |
To see the full peer comparison of Yeluri Formulations Private Limited, buy the company report.
Auditor
Yeluri Formulations Private Limited is audited by B NARSING RAO & CO LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B NARSING RAO & CO LLP | FY 2024 | 002409S |
Shareholding
The shareholding of Yeluri Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Yeluri Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2025 | 101161579 | Sidbi | ₹1.94 Cr | Open | |
| 30 Jun 2025 | 101118189 | Others | ₹2.57 Cr | Open | |
| 16 Oct 2024 | 100987382 | Others | ₹8 Cr | Open | |
| 18 Apr 2023 | 100711611 | Hdfc Bank Limited | ₹22.08 Lakh | Open | |
| 25 Feb 2020 | 100389471 | Hdfc Bank Limited | ₹44.59 Cr | Open |
To see the full charge records of Yeluri Formulations Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Yeluri Formulations Private Limited has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.05 Cr; the latest was in August 2022.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Yeluri Formulations Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Yeluri Formulations Private Limited has 17 court cases on record: 5 filed by Yeluri Formulations, 12 filed against it. 4 cases are pending and 13 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 9 | 3 |
| High courts | 6 | 3 | 1 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against M/S Strathspey Labs Pvt. Ltd., 1)Mr.Anshul Agarwal,2) Mr.Sonal Kasera,3) Mr.Raja Paul, | Disposed |
| High Court, West Bengal | Court case (CRR) | Filed by the company against Union of India | Pending |
| District court, Hooghly, West Bengal | Court case (C R Case) | Filed against the company by Union of India Rep. by Drungs Inspector | Pending |
| District court, Amritsar, Punjab | Criminal case | Filed against the company by State Through District Drug Inspector | Pending |
| District court, Dungarpur, Rajasthan | Court case (Cr. Misc. Cases) | Filed against the company by State From Drug Control Officer | Pending |
To see the full case history of Yeluri Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yeluri Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Yeluri Formulations Private Limited has a workforce of 69 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 69 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Yeluri Formulations Private Limited, buy the company report.
GST
Yeluri Formulations has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACY1267G1ZC | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Yeluri Formulations Private Limited, buy the company report.
Recent activity
Yeluri Formulations Private Limited has 8 board changes on record since 2009: 4 appointments and 4 cessations. The latest: Surya Prakasa Rao Yeluri ceased to be Managing Director on 04 Aug 2022.
30 earlier events are in the company report.
Frequently asked questions
Yeluri Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 1997 (29+ years old) and is registered under CIN U24230TG1997PTC026188.
Yeluri Formulations has 4 current directors:
- Yeluri Hari Prasad - Managing Director
- Manogna Yeluri - Additional Director
- Eluri Nageswara Rao - Director
- Eluri Sridevi - Director
The latest financial statements of Yeluri Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Yeluri Formulations is 36AAACY1267G1ZC, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Yeluri Formulations is U24230TG1997PTC026188. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yeluri Formulations has 17 court cases on record: 5 filed by the company and 12 filed against it. 4 are pending. Most are in the district courts.
Yeluri Formulations was incorporated on 15 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.
Yeluri Formulations has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.05 Cr; the latest was in August 2022.
The peers of Yeluri Formulations by revenue are Veer Chemie and Aromatics Pvt Ltd, Pharma Chem Industries (Gujarat) Private Limited, V S International Private Limited, XL Laboratories Private Limited, MCW Healthcare Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Surya Prakasa Rao Yeluri ceased to be Managing Director on 04 Aug 2022. Yeluri Hari Prasad ceased to be Director on 04 Aug 2022. Manogna Yeluri was appointed as Additional Director on 28 Jun 2021. Yeluri Formulations has 8 board changes on record in total.
Yes, Yeluri Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0004299).

